Dynamic conditional survival nomogram for primary hepatocellular carcinoma: a population-based analysis
Related Experiment Video
Updated: May 23, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Junling Zhao1, Jing Gao1, Wei Liu1
1Department of Oncology, Changle People's Hospital Affiliated to Shandong Second Medical University, Weifang, China.
Background And Purpose:
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide. While 5-year overall survival (OS) is a common prognostic metric, it does not reflect the evolving prognosis of long-term survivors. The study aimed to evaluate dynamic changes in real-time survival among HCC patients over time using conditional survival (CS) analysis and to develop an individualized, time-updated prognostic model.
Methods:
A total of 11,926 patients with primary HCC were included and randomly assigned to training (70%) and validation (30%) cohorts. CS was defined as the probability of surviving additional years given time already survived [CS(t1|t0) = OS(t1 + t0)/OS(t0), where OS(t0) represents the survival probability at t0-years from diagnosis, and OS(t0 + t1) represents survival at (t0 + t1)-years]. Univariable and multivariable Cox regressions were used to identify independent prognostic factors and construct a CS-nomogram. Model performance was assessed using area under the curve (AUC), calibration curves, and decision curve analysis.
Results:
CS analysis showed that real-time survival rate increased significantly with each additional year survived, with 5-year CS rising from 35.1% at diagnosis to 52.9%, 66.7%, 79.2%, and 90.2% after 1-4 years of survival. Eleven prognostic factors were included in the final model (all p < 0.05). The CS-nomogram demonstrated strong discrimination (5-year AUC > 0.84 in both cohorts) and good calibration. An interactive web-based tool was developed to facilitate clinical application.
Conclusion:
CS analysis offers more accurate and dynamic prognostic information for HCC patients. The CS-nomogram provides personalized, time-adjusted survival estimates, supporting more informed decision-making and survivorship care.
More Related Videos
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024